Koru Medical Systems (KRMD) closed at $3.70 on November 13, 2026, up 0.3% from the previous close, on volume of 197,890 shares (30-day average 186,984).
Data as of November 13, 2026.
13-Nov-2026
Repro-Med Systems Earnings Call Highlights Growth and Margins
TipRanks (Sat, 14-Nov 8:20 PM ET)
TipRanks (Wed, 11-Nov 8:40 AM ET)
Piper Sandler Sticks to Its Hold Rating for REPRO-MED Systems (KRMD)
TipRanks (Wed, 11-Nov 8:35 AM ET)
KORU Medical Systems Non-GAAP EPS of $0.02 beats by $0.04, revenue of $11.6M beats by $0.27M
Seeking Alpha News (Tue, 10-Nov 4:58 PM ET)
Business Wire (Tue, 10-Nov 4:05 PM ET)
Here are the major earnings after the close Tuesday
Seeking Alpha News (Tue, 10-Nov 10:00 AM ET)
KORU Medical Systems to Participate in Upcoming Investor Conferences
Business Wire (Wed, 4-Nov 4:05 PM ET)
KORU Medical Systems to Report Third Quarter 2026 Financial Results on November 10, 2026
Business Wire (Tue, 20-Oct 4:05 PM ET)
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
Koru Medical Systems trades on the NASDAQ stock market under the symbol KRMD.
As of November 13, 2026, KRMD stock price climbed to $3.70 with 197,890 million shares trading.
KRMD has a beta of 0.61, meaning it tends to be less sensitive to market movements. KRMD has a correlation of 0.02 to the broad based SPY ETF.
KRMD has a market cap of $170.84 million. This is considered a Micro Cap stock.
Last quarter Koru Medical Systems reported $12 million in Revenue and $.02 earnings per share. This beat revenue expectation by $244,000 and exceeded earnings estimates by $.04.
In the last 3 years, KRMD traded as high as $6.61 and as low as $1.86.
The top ETF exchange traded funds that KRMD belongs to (by Net Assets): IWM, VTI, IWO, VXF, VTWO.
KRMD has underperformed the market in the last year with a return of -14.9%, while SPY returned +13.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in KRMD shares. However, KRMD has outperformed the market in the last 3 month and 2 week periods, returning +11.3% and +23.7%, while SPY returned -2.8% and -0.2%, respectively. This indicates KRMD has been having a stronger performance recently.
KRMD support price is $3.52 and resistance is $3.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KRMD shares will trade within this expected range on the day.
